Problems In Laboratory Monitoring Of Heparin Dosage

This publication has 118 references indexed in Scilit:

• A proposed model to monitor heparin therapy using the concentrated thrombin time which allows standardisation of reagents and improved estimation of heparin concentrations
  Blood Coagulation & Fibrinolysis, 1996
• Utility of the Heptest and a Chromogenic Substrate Method to Assess Anticoagulation in Patients Refractory to Heparinization by the Activated Partial Thromboplastin Time Method
  Seminars in Thrombosis and Hemostasis, 1994
• Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous Thrombosis
  New England Journal of Medicine, 1990
• Changes of activated partial thromboplastin time during constant intravenous and fixed intermittent subcutaneous administration of heparin
  Journal of Internal Medicine, 1989
• Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction
  New England Journal of Medicine, 1989
• Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein Thrombosis
  New England Journal of Medicine, 1986
• Circadian changes in anticoagulant effect of heparin infused at a constant rate.
  BMJ, 1985
• Audit of control of heparin treatment.
  BMJ, 1985
• Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous Thrombosis
  New England Journal of Medicine, 1982
• The clinical usage of heparin
  The American Journal of Cardiology, 1964